CHRONOtype-adjusted DIET on Weight Loss (CHRONO-DIET)
Primary Purpose
Obesity
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
CHRONOTYPE-ADJUSTED DIET
Sponsored by

About this trial
This is an interventional treatment trial for Obesity focused on measuring Obesity, Appetite regulation, Chronotype, Diet
Eligibility Criteria
Inclusion Criteria:
- students or staff of the Catholic University of Murcia (UCAM), with an age ranged between 18 and 65 years old
Exclusion Criteria:
- clinically significant illnesses (including type 2 diabetes, chronic heart failure, hepatitis and cancer)
- those taking any medications known to affect body weight (thyroid hormones, corticosteroids, etc.)
- women in special physiological situations (pregnant, lactating).
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
CHRONOTYPE-ADJUSTED DIET
CONTROL
Arm Description
Patients that undergo a chronotype adjusted diet
Patients following a traditional or conventional hypocaloric diet
Outcomes
Primary Outcome Measures
Total weight loss, in percentage, from baseline to end-of-treatment
Percentage of weight loss, measured with a scale, from baseline weight (100% body weight) since body weight after 12 weeks of treatment (final body weight). Percentage of body weight was then measured as Total Weight Loss (%) = (Final body weight - Baseline body weight) / baseline body weight x 100.
Secondary Outcome Measures
BMI loss
BMI decrease from baseline
Anthropometrical and other clinical parameters
Improvement of anthropometrical and other clinical parameters during the treatment
Full Information
NCT ID
NCT03755674
First Posted
July 19, 2018
Last Updated
November 25, 2018
Sponsor
Universidad Católica San Antonio de Murcia
Collaborators
Hospital Universitario Virgen de la Arrixaca
1. Study Identification
Unique Protocol Identification Number
NCT03755674
Brief Title
CHRONOtype-adjusted DIET on Weight Loss
Acronym
CHRONO-DIET
Official Title
Influence of Chronobiological and Neuroendocrine Factors in Appetite Regulation and Obesity Treatment
Study Type
Interventional
2. Study Status
Record Verification Date
November 2018
Overall Recruitment Status
Completed
Study Start Date
January 10, 2015 (Actual)
Primary Completion Date
December 21, 2016 (Actual)
Study Completion Date
February 23, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universidad Católica San Antonio de Murcia
Collaborators
Hospital Universitario Virgen de la Arrixaca
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
BACKGROUND: Several reports have observed that the alteration of normal biological rhythms is associated with obesity development. In this regard, those subject with the preference for evening seems to be prone to develop obesity. However, the current treatment of obesity does not take into account these aspects OBJECTIVE: To evaluate whether a diet adjusted to patient's chronotype is more effective than the current dietary recommendations.
SUBJECTS/METHODS: 209 subjects take part in a randomized, double-blind clinical trial. 104 subjects followed a typical hypocaloric dietary treatment (CONTROL) and the other 105 subjects undergone a diet with a daily caloric distribution adjusted to their chronotype (CHRONO).
CONCLUSIONS: A chronotype-adjusted diet may be a promising alternative to the classical hypocaloric dietary treatment since the investigator's data indicate a higher effectiveness regarding weight loss when the diet was adjusted to the patient's chronotype.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
Keywords
Obesity, Appetite regulation, Chronotype, Diet
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
96 (Actual)
8. Arms, Groups, and Interventions
Arm Title
CHRONOTYPE-ADJUSTED DIET
Arm Type
Experimental
Arm Description
Patients that undergo a chronotype adjusted diet
Arm Title
CONTROL
Arm Type
No Intervention
Arm Description
Patients following a traditional or conventional hypocaloric diet
Intervention Type
Procedure
Intervention Name(s)
CHRONOTYPE-ADJUSTED DIET
Intervention Description
Those patients followed a daily caloric distribution attending to their chronotype. In this regards, 'morning' subjects ate a higher quantity of calories at the first part of the day, while 'evening' subjects ate a higher amount of calories at the second half of the day.
Primary Outcome Measure Information:
Title
Total weight loss, in percentage, from baseline to end-of-treatment
Description
Percentage of weight loss, measured with a scale, from baseline weight (100% body weight) since body weight after 12 weeks of treatment (final body weight). Percentage of body weight was then measured as Total Weight Loss (%) = (Final body weight - Baseline body weight) / baseline body weight x 100.
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
BMI loss
Description
BMI decrease from baseline
Time Frame
12 weeks
Title
Anthropometrical and other clinical parameters
Description
Improvement of anthropometrical and other clinical parameters during the treatment
Time Frame
12 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
students or staff of the Catholic University of Murcia (UCAM), with an age ranged between 18 and 65 years old
Exclusion Criteria:
clinically significant illnesses (including type 2 diabetes, chronic heart failure, hepatitis and cancer)
those taking any medications known to affect body weight (thyroid hormones, corticosteroids, etc.)
women in special physiological situations (pregnant, lactating).
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Juan José Hernández Morante, PhD
Organizational Affiliation
Universidad Católica San Antonio de Murcia
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
31153674
Citation
Galindo Munoz JS, Gomez Gallego M, Diaz Soler I, Barbera Ortega MC, Martinez Caceres CM, Hernandez Morante JJ. Effect of a chronotype-adjusted diet on weight loss effectiveness: A randomized clinical trial. Clin Nutr. 2020 Apr;39(4):1041-1048. doi: 10.1016/j.clnu.2019.05.012. Epub 2019 May 21.
Results Reference
derived
Learn more about this trial
CHRONOtype-adjusted DIET on Weight Loss
We'll reach out to this number within 24 hrs